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Abstract
Background: Viral and bacterial respiratory tract infections in early-life are linked to the development of allergic airway
inflammation and asthma. However, the mechanisms involved are not well understood. We have previously shown that
neonatal and infant, but not adult, chlamydial lung infections in mice permanently alter inflammatory phenotype and
physiology to increase the severity of allergic airway disease by increasing lung interleukin (IL)-13 expression, mucus hyper-
secretion and airway hyper-responsiveness. This occurred through different mechanisms with infection at different ages.
Neonatal infection suppressed inflammatory responses but enhanced systemic dendritic cell:T-cell IL-13 release and induced
permanent alterations in lung structure (i.e., increased the size of alveoli). Infant infection enhanced inflammatory responses
but had no effect on lung structure. Here we investigated the role of hematopoietic cells in these processes using bone
marrow chimera studies.
Methodology/Principal Findings: Neonatal (,24-hours-old), infant (3-weeks-old) and adult (6-weeks-old) mice were
infected with C. muridarum. Nine weeks after infection bone marrow was collected and transferred into recipient age-
matched irradiated naı¨ve mice. Allergic airway disease was induced (8 weeks after adoptive transfer) by sensitization and
challenge with ovalbumin. Reconstitution of irradiated naı¨ve mice with bone marrow from mice infected as neonates
resulted in the suppression of the hallmark features of allergic airway disease including mucus hyper-secretion and airway
hyper-responsiveness, which was associated with decreased IL-13 levels in the lung. In stark contrast, reconstitution with
bone marrow from mice infected as infants increased the severity of allergic airway disease by increasing T helper type-2 cell
cytokine release (IL-5 and IL-13), mucus hyper-secretion, airway hyper-responsiveness and IL-13 levels in the lung.
Reconstitution with bone marrow from infected adult mice had no effects.
Conclusions: These results suggest that an infant chlamydial lung infection results in long lasting alterations in
hematopoietic cells that increases the severity of allergic airway disease in later-life.
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Introduction
Asthma is a chronic inflammatory disease of the airways that is
particularly common in children. The clinical course of asthma is
punctuated by recurring exacerbations that are underpinned by
aberrant CD4+ T helper type 2 lymphocyte (Th2 cell) responses to
environmental stimuli [1]. The hallmark symptoms of asthma are
mucus hyper-secretion and airway hyper-responsiveness (AHR)
that lead to occlusion of the airways, restricted airflow, breathing
difficulties and wheezing. These symptoms are driven by the pro-
asthmatic Th2 cell-associated cytokines interleukin (IL)-4, -5 and -
13 (reviewed in [1,2]). Viral (particularly rhinovirus and respira-
tory syncytial virus) and bacterial (particularly Chlamydia and
Mycoplasma) infections in early-life are thought to contribute to the
development of asthma [3,4,5,6,7,8].
The etiology of asthma suggests that altered immunological
programming in early-life by specific infections may play critical
roles in the induction and progression of the disease. There is
emerging evidence to suggest that both the nature and timing of
infection is pivotal in determining whether specific infections
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protect or predispose to asthma. Numerous studies show an
inverse association between Th1-inducing infections and the
development of asthma [9,10,11]. However, infection with the
intracellular bacterium Chlamydia pneumoniae is a notable exception
and is increasingly linked with the development of asthma in both
children and adults [4,5,7,8,12].
Respiratory infections with C. pneumoniae are common and
usually asymptomatic but are responsible for up to 22% of all cases
of community-acquired pneumonia requiring hospitalization
[13,14]. Significantly, 50–80% of young adults have anti-C.
pneumoniae antibodies [15,16], indicating the high prevalence of
chlamydial respiratory tract infections in the community during
the earlier stages of life. Resolution of infection is mediated by Th1
and interferon (IFN)-c-driven responses [17,18]. However, how
Th1-inducing chlamydial lung infections are associated with
increasing the severity of Th2-mediated asthma remain poorly
understood. We have previously shown that Chlamydia can infect
dendritic cells (DCs) and subvert their function to induce Th2
responses and AHR [19,20]. We have also shown that the Th2
cytokine IL-13, which is increased in the airways of asthmatics,
enhances susceptibility to chlamydial infections in mice [21].
Furthermore we have recently demonstrated that chlamydial lung
infection in early-life increases the severity of allergic airway
disease (AAD) in later-life [7]. Infection of both neonatal and
infant, but not adult, BALB/c mice increased the expression of IL-
13 in the lungs, the numbers of mucus secreting cells (MSC)
around the airways and AHR during AAD in later-life [7]. We
have begun to elucidate the mechanisms involved. Neonatal
infection suppressed eosinophilic and Th2-mediated allergic
inflammation, but increased systemic DC:T cell IL-13 release
and altered lung structure by increasing the size of alveoli [7]. By
contrast, infant infection enhanced eosinophilic and Th2-mediated
allergic inflammation, but did not alter lung structure [7]. These
results suggest that hematopoietic cells may have differential
contributions to the mechanisms through which neonatal and
infant infections increase the severity of AAD.
Recent studies suggest that hematopoietic cells can respond
directly to infections and inflammatory signals [22]. These cells
give rise to myeloid and lymphoid immune cell lineages and can
proliferate, and differentiate, to replace immune cells lost to cell
death following infection. Hematopoietic cells have been shown to
sense pathogen components directly via toll-like receptors (TLRs)
[23]. Infection-induced, pro-inflammatory cytokine release may
also activate hematopoietic cells [24,25] and aberrant cytokine-
induced signalling may have negative effects on the function of
these cells [24,25]. This may have long-term effects on the
programming of the immune system and the nature of subsequent
responses to antigens.
The effects of chlamydial lung infection on hematopoietic cell
function and subsequent AAD have not been investigated. In this
study, we demonstrate that reconstitution of bone marrow from
mice infected with C. muridarum as infants, but not neonates,
increases the severity of AAD in later-life. Therefore, early-life
infection-induced alterations in hematopoietic cells may play a
previously unrecognised role in predisposing to severe AAD.
Materials and Methods
Ethics Statement
All experiments were performed with approval from the animal
ethics committees of The University of Newcastle and Garvan
Institute/St. Vincent’s Hospital, NSW.
Animals
Specific pathogen-free pregnant and non-pregnant BALB/c
mice (6, 9, 12 or 15 week old) were obtained from the central
animal house, The University of Newcastle or from Australian
BioResources (Moss Vale, Australia).
C. muridarum lung infection
Neonatal (,24 hour old), infant (3 weeks old) or adult (6 weeks
old) BALB/c mice were infected intranasally with C. muridarum
(400 [neonate] or 100 [infant and adult] inclusion-forming units,
ATCC VR-123, in 5 ml (neonate) or 30 ml (infant and adult)
sucrose phosphate glutamate buffer [vehicle]) [6,7,26]. Controls
were sham inoculated with equivalent volumes of vehicle
intranasally.
Generation of bone marrow chimeras and induction of
AAD
Nine weeks after neonatal, infant or adult infection, or sham
inoculation, bone marrow was extracted from the hind limbs of
donor mice and 16107 cells were intravenously transferred to
recipient age-matched irradiated naı¨ve BALB/c mice. Recipient
mice were irradiated twice (four hours between each irradiation)
with 450RAD (4.5 Gy) prior to adoptive transfer of bone marrow
[27]. The mice were left for a period of 8 weeks to allow for
reconstitution of bone marrow and hematopoietic cells. It has been
shown previously [27], that this method is sufficient for bone
marrow reconstitution. AAD was then induced as previously
described [6,7,28,29]. Mice were sensitized intraperitoneally to the
model allergen Ovalbumin (Ova, 50 mg, Sigma, Missouri, USA) in
Rehydrogel (1 mg, Reheis, Berkeley Heights, USA) in sterile saline
(200 ml) and subsequently challenged 12 days later by intranasal
administration of Ova (10 mg in 50 ml sterile saline) for 4
consecutive days. Mice were sacrificed 24 hours after the final
Ova challenge and features of AAD were assessed (Figure 1).
Determination of mediastinal lymph node cell cytokine
release
Mediastinal lymph node (MLN) cells were excised, single cell
suspensions prepared, erythrocytes lysed and 16106 MLN cells
plated out in 96 well culture plates in 200 ml of RPMI 1640 culture
medium containing 10% FCS, 2 mM L-glutamine, 2 mM sodium
pyruvate, 100 mg/ml penicillin, 100 mg/ml streptomycin, 50 mM
2-mercaptoethanol (GIBCO, Invitrogen Mount Waverly, Austra-
lia). Cells were re-stimulated with Ova (200 mg/mL; Sigma) for 4
days and the concentration of IL-5, IL-13 and IFN-c in
supernatants were analyzed by ELISA using paired antibodies
(R&D systems, Gymea, Australia) as we have previously described
[6,7,28,29,30,31,32,33].
Quantification of airway MSCs
Lungs were formalin-fixed, embedded, and sectioned (4–6 mm).
Sections were stained with periodic acid–schiff for enumeration of
MSCs in the airways as we have previously described [32,34].
Assessment of lung function
Lung function, in terms of AHR, was measured in anesthetized
mice using whole-body plethysmography by determination of
transpulmonary resistance and dynamic compliance in response to
increasing doses of nebulized methacholine (Sigma) as we have
previously described [6].
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Quantification of IL-13 protein in lung homogenates
Whole lungs were homogenized in 1 mL of RIPA buffer
(Sigma) and total protein was extracted according to manufactur-
ers recommendations. Extracted total protein from lung homog-
enates was quantified using BCA Protein Assay Kits (Pierce,
Scorsby, Australia). IL-13 protein in lung homogenates was
analyzed by ELISA (R&D systems).
Data analysis
Results are presented as means 6 SEM with each experimental
group consisting of 6–8 mice, from two independent experiments (3–
4 mice per experiment). Each experimental age group was run in
parallel with its age-matched control. Between group comparisons of
transpulmonary resistance and dynamic compliance (whole curve
analysis) were performed using One-way repeated-measures AN-
OVA. The Mann-Whitney non-parametric test was used for all other
comparisons. Analyses were conducted using GraphPad Prism 5
(GraphPad Software, La Jolla, USA). Analysis of statistical outliers
was performed using the Grubb’s outlier test for GraphPad Prism 5.
Results
Establishment of AAD in bone marrow chimeras
To establish the chimera system, bone marrow was extracted
from naı¨ve (i.e. un-infected) BALB/c mice and transferred to age-
matched irradiated naı¨ve mice. After reconstitution of hematopoi-
etic cells (8 weeks later), AAD was induced and assessed. Allergic
mice (Chimera+Ova groups) had significantly increased AHR
(increased transpulmonary resistance (Figure 2A) and decreased
dynamic compliance (Figure 2B)) compared to non-allergic
(Chimera+Sham) controls. They also had increased MSC numbers
around the airways (Figure 2C) and Ova-specific Th2 (IL-5 and IL-
13), but not Th1 (IFN-c [data not shown]) cytokine release from
MLN cells restimulated with Ova (Figure 2D–E). Allergic mice also
had significantly increased IL-13 in the lung (Figure 2F) compared
to non-allergic (Chimera+Sham) controls. Notably, the develop-
ment of AAD in chimeras did not involve the influx of eosinophils
into the lung (data not shown). These results demonstrate that AAD
could be induced after reconstitution of bone marrow.
C. muridarum lung infection in infants, but not neonates,
alters hematopoietic cells to increase Ova-specific Th2
cytokine release from MLN cells during AAD
We have previously shown that neonatal infection suppressed,
whereas infant infection increased Ova-specific Th2 cytokine (IL-5
and IL-13) release from MLN cell cultures, whilst an adult
infection had no effect [7]. Here we show that reconstitution of
naı¨ve mice with bone marrow from mice infected (C. muridarum
Chimera+Ova) as neonates had no effect on Ova-specific IL-5 or
IL-13 release in AAD compared to age-matched, un-infected
allergic (Vehicle Chimera+Ova) controls (Figure 3A). In contrast,
reconstitution with bone marrow from mice infected as infants
increased IL-5 and IL-13 release from MLN cells in AAD
(Figure 3B). Reconstitution with bone marrow from mice infected
as adults increased IL-5 but had no effect on IL-13 release
(Figure 3C). These results suggest that infant, but not neonatal or
adult infection, alters hematopoietic cells within the bone marrow
to promote increased Th2 cytokine release in AAD.
C. muridarum lung infection in infants, but not neonates,
alters hematopoietic cells to induce MSC hyperplasia
during AAD
We have previously shown that neonatal and infant, but not adult
chlamydial lung infection results in increased MSC numbers in the
airways during AAD in later-life [7]. Reconstitution of naı¨ve mice
with bone marrow from mice infected (C. muridarum Chimera+Ova)
as neonates resulted in a small but significant reduction, whilst bone
marrow from mice infected as infants increased the number of MSCs
in the airways in AAD, compared to age-matched, un-infected
allergic (Vehicle Chimera+Ova) controls (Figure 4A and 4B,
respectively). Reconstitution with bone marrow from mice infected
as adults had no effect (Figure 4C). These results suggest that infant,
but not neonatal or adult infection, alters hematopoietic cells within
the bone marrow, leading to increased MSC numbers in AAD.
C. muridarum lung infection in infants, but not neonates,
alters hematopoietic cells to increase AHR during AAD
We have previously shown that neonatal and infant, but not adult
chlamydial lung infection increases AHR during AAD in later-life [7].
Thus, we investigated whether infection in early-life altered
hematopoietic cells to increase AHR. Reconstitution of naı¨ve mice
with bone marrow from mice infected (C. muridarum Chimera+Ova)
as neonates suppressed transpulmonary resistance during AAD,
compared to age-matched, un-infected allergic (Vehicle Chimer-
a+Ova) controls (Figure 5A). In stark contrast, reconstitution with
bone marrow from mice infected as infants increased transpulmonary
resistance (Figure 5B). An adult infection had no effect (Figure 5C).
Reconstitution with bone marrow from mice infected as neonates,
infants or adults had no effect on dynamic compliance during AAD
(data not shown). These results suggest that infant, but not neonatal or
adult infection, alters hematopoietic cells within the bone marrow
and promotes increased AHR in AAD.
Figure 1. Experimental protocol. BALB/c mice were infected intranasally with C. muridarum as neonates (,24 hours old), infants (3 weeks old) or
adults (6 weeks old). Controls were inoculated with vehicle (sucrose phosphate glutamate buffer). Nine weeks (63 days) after inoculation, bone
marrow was extracted and reconstituted into age-matched irradiated, naive mice. The mice were left for a period of 8 weeks to allow for
reconstitution of hematopoietic cells. Mice were then sensitized intraperitoneally (Day 120) to Ovalbumin (Ova) and subsequently challenged 12 days
later by intranasal administration of Ova for 4 consecutive days (Day 132–135). Mice were sacrificed 24 hours after the final Ova challenge (Day 136)
and features of AAD were assessed.
doi:10.1371/journal.pone.0042588.g001
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Figure 2. Characterization of AAD in bone marrow chimeras. Bone marrow from adult naı¨ve BALB/c mice was adoptively transferred into age-
matched irradiated, naı¨ve mice. Eight weeks later, after bone marrow reconstitution, chimeras were subjected to Ova-induced AAD and the
development of AAD was assessed. (A) Transpulmonary resistance, (B) dynamic compliance, (C) mucus secreting cell (MSCs) within 100 mM of
basement membrane (BM) in the airways, and Ova-specific (D) IL-5 and (E) IL-13 release from re-stimulated MLN cell culture supernatants. Results are
represented as mean 6 SEM. n= 6–8, from two independent experiments of 3–4 mice. *P,0.05 compared to non-allergic (Chimera + Sham) control.
ND=not detected.
doi:10.1371/journal.pone.0042588.g002
Figure 3. C. muridarum lung infection in infants, but not neonates, alters hematopoietic cells to increase Th2 cytokine release from
MLN cells. BALB/c mice were infected with C. muridarum or sham inoculated (Vehicle) as neonates, infants or adults. Nine weeks after infection bone
marrow was extracted and adoptively transferred into age-matched irradiated, naı¨ve mice. Eight weeks after bone marrow reconstitution, chimeras
were subjected to Ova-induced AAD and the development of AAD was assessed. Ova-induced (A–C) IL-5 and (D–F) IL-13 release in MLN cell cultures
from neonate, infant and adult bone marrow chimeras. Results are represented as mean 6 SEM. n = 6–8, from two independent experiments of 3–4
mice. Age-matched controls were run in parallel with every experiment. *P,0.05 compared to un-infected allergic (Vehicle Chimera + Ova) controls.
doi:10.1371/journal.pone.0042588.g003
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C. muridarum lung infection in infants alters
hematopoietic cells to increase IL-13 in the lung during
AAD
Given that MLN IL-13 release did not correlate with decreased
MSC numbers and transpulmonary resistance in the neonatal
group, we assessed IL-13 protein in the lung. Reconstitution of
naı¨ve mice with bone marrow from mice infected (C. muridarum
Chimera+Ova) as neonates suppressed IL-13 production during
AAD, compared to age-matched, un-infected allergic (Vehicle
Chimera+Ova) controls (Figure 6A). In stark contrast, reconstitu-
tion with bone marrow from mice infected as infants increased IL-
13 production in the lung (Figure 6B). An adult infection had no
effect (Figure 6C). These results suggest that an infant infection
alters hematopoietic cells within the bone marrow and promotes
increased IL-13 in the lung during AAD.
Discussion
In this investigation we demonstrate that C. muridarum lung
infection in infants alters cells in the bone marrow to increase the
severity of AAD in later-life. It is most likely that hematopoietic
cells are the cells that are affected. We first developed a model of
Ova-induced AAD, which has mucus hypersecretion and AHR as
hallmark features, in a chimeric system. We then used this model
to show that chlamydial lung infection in infants had long lasting
effects on bone marrow cells. When bone marrow was transferred
into irradiated naı¨ve recipients nine weeks after infant infection,
the release of pro-asthmatic Th2-associated cytokines (IL-5 and
IL-13) from MLN cells, MSC numbers around the airways,
transpulmonary resistance and IL-13 levels in the lung were all
increased during Ova-induced AAD. Adoptive transfer of bone
marrow from mice infected as neonates had no effect on Th2-
cytokine release, and suppressed the number of MSCs around the
airways, transpulmonary resistance and IL-13 in the lung.
Infection of adult mice had minimal effects. Therefore, an infant,
but not neonatal, chlamydial lung infection, increases AAD in
later-life through mechanisms that involve alterations in either the
number or phenotype of hematopoietic cells. This is the first study
to show that the age of infection can have differential effects on
hematopoietic cells resulting in either enhanced, or suppressed,
AAD in later-life.
Figure 4. C. muridarum lung infection in infants, but not neonates, alters hematopoietic cells to induce MSC hyperplasia. BALB/c mice
were infected with C. muridarum or sham inoculated (vehicle) as neonates, infants or adults. Nine weeks after infection bone marrow was extracted
and adoptively transferred into age-matched irradiated, naı¨ve mice. Eight weeks after bone marrow reconstitution, chimeras were subjected to Ova-
induced AAD and the development of AAD was assessed. Numbers of mucus secreting cells (MSCs) within 100 mm of basement membrane (BM) in
the airways of (A) neonate, (B) infant and (C) adult bone marrow chimeras. Results are represented as mean 6 SEM. n = 6–8, from two independent
experiments of 3–4 mice. Age-matched controls were run in parallel with every experiment. *P,0.05 compared to un-infected allergic (Vehicle
Chimera + Ova) controls.
doi:10.1371/journal.pone.0042588.g004
Figure 5. C. muridarum lung infection in infants, but not neonates, alters hematopoietic cells to increase AHR during AAD. BALB/c
mice were infected with C. muridarum or sham inoculated (vehicle) as neonates, infants or adults. Nine weeks after infection bone marrow was
extracted and adoptively transferred into age-matched, irradiated naı¨ve mice. Eight weeks after bone marrow reconstitution, chimeras were
subjected to Ova-induced AAD and the development of AAD was assessed. Transpulmonary resistance at the maximal dose of methacholine
administered (10 mg/mL) in (A) neonate, (B) infant and (C) adult bone marrow chimeras. Results are represented as mean 6 SEM. n = 6–8, from two
independent experiments of 3–4 mice. Age-matched controls were run in parallel with every experiment. *P,0.05 compared to un-infected allergic
(Vehicle Chimera + Ova) controls.
doi:10.1371/journal.pone.0042588.g005
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In contrast to the affects on transpulmonary resistance, dynamic
compliance was unaffected. The large airways are the major
contributors to transpulmonary resistance, whereas dynamic
compliance is a measure of the elasticity of the small airways
and parenchyma [35]. It is likely therefore that infection-induced
changes to hematopoietic cells predominantly affected the larger
airways in this study. This is supported by the observations that
MSC numbers around the large airways were also altered.
There were no differences in all except one of the features of
AAD in chimeras generated from sham-inoculated mice. There
were no differences between the allergic controls from the three
different age groups (Vehicle+Chimera) in terms of MSC
numbers, transpulmonary resistance or IL-13 protein in the lung
during AAD. This demonstrates that the bone marrow of the
chimeras was reconstituted to the same level. The only difference
was in the magnitude of MLN cytokine release into culture
supernatants. The MLN culture experiments were performed at
different times for the different groups. This assay is an ex vivo 6
day cell culture assay that is subject to day to day variation and
results are compared between groups performed at the same time
and not between different experiments carried out at different
times. It is not as robust as MSC enumeration, lung function and
IL-13 protein in the lung, all of which are direct representations of
what occurred in vivo.
Notably all mice were adults at the time bone marrow was
extracted and reconstituted. Mice infected or sham-inoculated as
neonates, infants or adults were 9, 12 and 15 weeks old at time of
bone marrow extraction and reconstitution, respectively. Bone
marrow was reconstituted into age-matched controls (9, 12 and 15
week old mice for neonate, infant and adult groups, respectively).
Each infected group was compared to its relevant age-matched
sham-inoculated control, which was run in parallel with each
experiment.
For this study we have used an Ova-induced model of AAD,
which involves systemic sensitization and airway challenge.
Asthma does have a systemic component although it manifests
in the respiratory system. We have previously demonstrated that
early-life Chlamydia lung infection drives more severe Ova-induced
AAD in later-life [7]. Thus, the use of this model allowed us to
investigate the effects of infection-induced changes in the bone
barrow compartment on infection-enhanced AAD in later-life.
Our study could be extended by using a house dust mite model of
AAD in which sensitization occurs through the respiratory mucosa
[34]. Such a study would answer different but important questions
that relate to how infection-induced changes in the bone marrow
affect mucosal sensitization.
Our results which show that neonatal infection alters hemato-
poietic cells to suppress, rather than promote the development of
AAD in later-life both support and contrast with what we observed
in intact (i.e. wild type) mice in our previous studies [6,7]. In the
previous studies neonatal infection also suppressed Th2 and
inflammatory responses. However, infection at this age increased
MSC and AHR and thus the severity of AAD by inducing systemic
IL-13 responses and altering lung structure. The enhanced IL-13
responses involved increased expression in the lung and systemic
DC:T-cell release, which correlated with increased MSC numbers
and AHR [7]. This contrasts with our current study, which shows
that IL-13 protein levels were decreased in the lungs. This
indicates that this component of the effects of a neonatal infection
does depend on hematopoietic cells. However, we did not
investigate the effects of infection on systemic DC:T-cell release
in this study. The alterations in lung structure involved alveolar
enlargement, which may significantly contribute to changes in
lung function [7]. Increased alveolar diameter results in the
reduction of alveolar attachments to the airway wall, which
decreases airway support and elastic recoil and may lead to
enhanced transpulmonary resistance and reduced tissue compli-
ance [36]. The effects on IL-13 responses and lung structure are
unlikely to be controlled by the hematopoietic system and in the
current study it is not surprising that neonatal infection does not
increase the severity of AAD through these processes.
Neonatal infection did not alter the release of IL-5 or IL-13
from Ova-stimulated MLN cells but reduced MSC numbers and
AHR, which was associated with attenuated IL-13 production in
the lung. It is likely that reductions in IL-13 production in the lung
contribute to the reductions in MSC numbers and AHR. Potential
explanations for these differential effects in MLNs and lungs are
that infection may have differential effects on different compart-
ments so that T-cells in the MLNs can still release sufficient
amounts of IL-5 and IL-13, but they may not be able to migrate to
the lung to induce MSC hyperplasia and AHR. Another
explanation could be that systemic DC and/or T-cell function
could be altered. Neonatal infection-induced changes in lung
structure in intact wild-type mice is also likely to contribute to
infection-induced severe AAD [7].
In contrast to what occurred in neonates, infection of infants
altered hematopoietic cells to increase the severity of AAD in later-
life by increasing Th2 (IL-5 and IL-13) cytokine release from MLN
cells, MSC numbers, transpulmonary resistance and IL-13
production in the lung. This is consistent with what occurs in
intact mice, where infection of infants increased the release of the
pro-asthmatic Th2 cytokines IL-5 and IL-13, which was associated
Figure 6. C. muridarum lung infection in infants, but not neonates, alters hematopoietic cells to increase IL-13 in the lung during
AAD. BALB/c mice were infected with C. muridarum or sham inoculated (vehicle) as neonates, infants or adults. Nine weeks after infection bone
marrow was extracted and adoptively transferred into age-matched, irradiated naı¨ve mice. Eight weeks after bone marrow reconstitution, chimeras
were subjected to Ova-induced AAD and the development of AAD was assessed. IL-13 protein in lung homgenates (A) neonate, (B) infant and (C)
adult bone marrow chimeras. Results are represented as mean 6 SEM. n= 6–8, from two independent experiments of 3–4 mice. Age-matched
controls were run in parallel with every experiment. *P,0.05 compared to un-infected allergic (Vehicle Chimera + Ova) controls.
doi:10.1371/journal.pone.0042588.g006
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with increases in MSC numbers and AHR [7]. Interestingly, an
infant infection did not result in alveolar enlargement in later-life
[7]. Thus, an infant infection may induce long lasting alterations in
hematopoietic cells, which drives enhanced AAD in later-life. This
study, therefore, extends our previous study by providing evidence
of how an infant infection enhances the severity of AAD.
There is mounting evidence that supports a role for infections in
altering hematopoietic cells. Hematopoietic progenitors express
TLRs that enable these cells to directly sense bacterial components
[23]. Upon TLR stimulation these progenitors preferentially
differentiate into myeloid cells, which allows for the rapid
replenishment of innate immune cells during infection [23].
Hematopoietic cells can also respond to pro-inflammatory
cytokines, which may alter their behaviour [22,37,38]. Infection
may also promote the migration of effector cells back to the bone
marrow, which may alter the signature and epigenetic profile of
immature bone marrow progenitors. Thus, respiratory C.
muridarum infection in infants may induce TLR, cytokine and
immune cell responses that may promote permanent alterations in
the phenotype or activity of hematopoietic cells that drive the
development of severe AAD. These possibilities are the subject of
ongoing investigations.
In summary, C. muridarum lung infection in infancy promotes
permanent alterations in hematopoietic cells that drive the develop-
ment of more severe AAD in later-life. Further studies into the effect of
respiratory chlamydial infection on hematopoietic cell differentiation
and function, as well as elucidating the role of TLR and cytokine
responses, will provide a mechanistic insight into how respiratory
chlamydial infections in early-life may increase the severity of AAD in
later-life. Such studies may identify new therapeutic targets for the
prevention of infection-associated severe asthma.
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